Home > Publications database > The case for biotechnological exceptionalism |
Journal Article | FZJ-2021-02705 |
2021
Springer Science + Business Media B.V
Dordrecht [u.a.]
This record in other databases:
Please use a persistent id in citations: http://hdl.handle.net/2128/29007 doi:10.1007/s11019-021-10032-5
Abstract: Do biomedical interventions raise special moral concerns? A rising number of prominent authors claim that at least in the case of biomedical enhancement they do not. Treating biomedical enhancements different from non-biomedical ones, they claim, amounts to unjustified biomedical exceptionalism. This article vindicates the familiar thesis that biomedical enhancement raises specific concerns. Taking a close look at the argumentative strategy against biomedical exceptionalism and provides counterexamples showing that the biomedical mode of interventions raises concerns not relevant otherwise. In particular, biomedical interventions throughout raise concerns of informed consent, which only rarely turn up in comparable non-biomedical interventions.
![]() |
The record appears in these collections: |